Nachrichten zur BIOGAIA AB B O.N. Aktie

Often considered as our “second brain”, the human gut and its resident microbiota play a crucial bidirectional role communicating the…

We are proud to announce that the scientific rationale and identification of our newly patented strain, Limosilactobacillus reuteri BG-R46®, has…

BioGaia AB (publ) will hold an Extraordinary General Meeting at 16 p.m. on 22 August 2025, at Klara Konferens &…

BioGaias (NASDAQ: BIOG) financial report for the second quarter of 2025 will be published at approximately 8:00 AM CEST on…

The number of votes in BioGaia decreased during May as a result of the conversion of a total of 1,038,202…

BioGaia has been recognized by TIME Magazine´s and Statista’s prestigious list of the World’s Top 500 Companies Pairing Growth with…

The Annual General Meeting of BioGaia AB (publ) on 7 May 2025 voted, among other things, to approve the following…

BioGaia AB (NASDAQ: BIOG) announces that Annwall & Rothschild Investments AB (owned by Jan Annwall and BioGaia’s Chairman Peter Rothschild),…

BioGaias (NASDAQ: BIOG) financial report for the fourth quarter of 2024 will be published at approximately 8:00 AM CET on…

We are proud to launch BioGaia® Gastrus® PURE ACTION, a clean ingredient, double-strength, FODMAP-friendly probiotic designed to support individuals with…

BioGaia AB (NASDAQ: BIOG) announces that Anatom Holding AG, a Switzerland-based investment firm, has acquired 4,979,813 class B shares in…

(Figures in the brackets refer to the same period the previous year) During the third quarter of 2024, BioGaia will record…

BioGaias (NASDAQ: BIOG) financial report for the third quarter of 2024 will be published at approximately 8:00 AM CEST on…

The number of shares and votes in BioGaia AB (publ) increased in September due to the exercise of some warrants…

The number of shares and votes in BioGaia AB (publ) increased in August due to the exercise of some warrants…

The number of shares and votes in BioGaia AB (publ) increased in July due to the exercise of some warrants…

BioGaias (NASDAQ: BIOG) financial report for the second quarter of 2024 will be published at approximately 8:00 AM CEST on…

BioGaia AB, a Swedish world-leading probiotics company, is establishing its own distribution in Australia and New Zealand through two newly…

The Annual General Meeting of BioGaia AB (publ) on 7 May 2024 voted, among other things, to approve the following…

BioGaias (NASDAQ: BIOG) financial report for the first quarter of 2024 will be published at approximately 8:00 AM CEST on…

BioGaia AB (publ) will hold its Annual General Meeting at 4:00 p.m. on Tuesday, 7 May 2024, at Klara Konferens…

The BioGaia (NASDAQ: BIOG) Annual and Sustainability Report 2023, including Corporate Governance Report 2023, and the Remuneration Report 2023 in…